Contra-indicated in patients with known hypersensitivity to vancomycin.
- TRADE NAME: Vibativ (Astellas)
- INDICATIONS: Complicated skin and skin structure infections (cSSSI)
- CLASS: Antibiotic, Antibiotic; lipoglycopeptide, Antimicrobial
- HALF-LIFE: 7–10 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alfuzosin, Artemether/Lumefantrine, BCG Vaccine, Chloroquine, Ciprofloxacin, Dronedarone, Gadobutrol, Indacaterol, Nilotinib, Pimozide, QT prolonging agents, Quetiapine, Quinine, Tetrabenazine, Thioridazine, Toremifene, Typhoid Vaccine, Vandetanib, Vemurafenib, Ziprasidone
- See adverse reactions attributed to class:
FETAL RISK
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
